Twist Bioscience Corporat... (TWST)
NASDAQ: TWST
· Real-Time Price · USD
28.04
-0.08 (-0.28%)
At close: Aug 18, 2025, 3:59 PM
28.39
1.25%
After-hours: Aug 18, 2025, 06:20 PM EDT
-0.28% (1D)
| Bid | 27.91 |
| Market Cap | 1.69B |
| Revenue (ttm) | 362.27M |
| Net Income (ttm) | -85.19M |
| EPS (ttm) | -1.44 |
| PE Ratio (ttm) | -19.47 |
| Forward PE | -19.15 |
| Analyst | Buy |
| Ask | 28.59 |
| Volume | 990,795 |
| Avg. Volume (20D) | 1,333,669 |
| Open | 28.07 |
| Previous Close | 28.12 |
| Day's Range | 27.83 - 28.33 |
| 52-Week Range | 24.28 - 55.33 |
| Beta | 2.37 |
About TWST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TWST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TWST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Twist Bioscience Corporation is scheduled to release its earnings on
Nov 17, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-10.3%
Twist Bioscience shares are trading lower after th...
Unlock content with
Pro Subscription
3 months ago
-8.44%
Twist Bioscience shares are trading lower after the company reported a Q2 EPS miss.
2 weeks ago · seekingalpha.com
Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call TranscriptTwist Bioscience Corporation (NASDAQ:TWST ) Q3 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Adam Laponis - Chief Financial Officer Angela Bitting - Chief Corporate Resp...
2 weeks ago · businesswire.com
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial ResultsSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter...
